300194 福安药业
已收盘 02-27 15:00:00
资讯
新帖
简况
福安药业:公司目前并未开展具体的AI研究项目
证券之星 · 02-27 13:00
福安药业:公司目前并未开展具体的AI研究项目
福安药业:公司目前没有接入AI智能创新药领域
互动易 · 02-27 12:51
福安药业:公司目前没有接入AI智能创新药领域
福安药业最新公告:子公司收到药品注册证书
证券之星 · 02-26 08:56
福安药业最新公告:子公司收到药品注册证书
福安药业(300194.SZ):吲哚布芬片获药品注册证书
智通财经 · 02-26 07:56
福安药业(300194.SZ):吲哚布芬片获药品注册证书
福安药业:公司的主要业务为化学制药,目前暂无中药种植基地
证券之星 · 02-25 09:30
福安药业:公司的主要业务为化学制药,目前暂无中药种植基地
福安药业2月25日现1笔大宗交易 成交金额915.99万元
新浪证券-红岸工作室 · 02-25 09:00
福安药业2月25日现1笔大宗交易 成交金额915.99万元
福安药业:公司目前没有海外大麻业务,除产品出口外无其他相关海外业务
证券之星 · 02-17
福安药业:公司目前没有海外大麻业务,除产品出口外无其他相关海外业务
每周股票复盘:福安药业(300194)子公司获药品注册证书,丰富产品线提升竞争力
证券之星 · 02-14
每周股票复盘:福安药业(300194)子公司获药品注册证书,丰富产品线提升竞争力
福安药业:公司将进一步严格遵守环保法规,达标合规排放
证券之星 · 02-11
福安药业:公司将进一步严格遵守环保法规,达标合规排放
福安药业最新公告:子公司收到盐酸咪达唑仑口服溶液药品注册证书
证券之星 · 02-10
福安药业最新公告:子公司收到盐酸咪达唑仑口服溶液药品注册证书
福安药业(300194.SZ)全资子公司收到药品注册证书
智通财经 · 02-10
福安药业(300194.SZ)全资子公司收到药品注册证书
福安药业:截止1月27日,公司股东户数为41762户
证券之星 · 02-06
福安药业:截止1月27日,公司股东户数为41762户
福安药业:截止1月10日,公司股东户数为41792户
证券之星 · 01-14
福安药业:截止1月10日,公司股东户数为41792户
福安药业:子公司二甲双胍恩格列净片获药品注册证书 有助于进一步丰富其产品线
中国财富通 · 01-09
福安药业:子公司二甲双胍恩格列净片获药品注册证书 有助于进一步丰富其产品线
福安药业最新公告:子公司庆余堂收到药品注册证书
证券之星 · 01-09
福安药业最新公告:子公司庆余堂收到药品注册证书
福安药业(300194.SZ):二甲双胍恩格列净片取得药品注册证书
智通财经 · 01-09
福安药业(300194.SZ):二甲双胍恩格列净片取得药品注册证书
福安药业(300194)1月7日主力资金净买入1577.29万元
证券之星 · 01-08
福安药业(300194)1月7日主力资金净买入1577.29万元
1月6日福安药业涨5.83%,万家国证2000指数增强A基金重仓该股
证券之星 · 01-06
1月6日福安药业涨5.83%,万家国证2000指数增强A基金重仓该股
福安药业:公司股东户数为42156户
金融界 · 2024-12-31
福安药业:公司股东户数为42156户
福安药业:子公司持有富马酸替诺福韦二吡呋酯原料药批件
金融界 · 2024-12-31
福安药业:子公司持有富马酸替诺福韦二吡呋酯原料药批件
加载更多
公司概况
公司名称:
福安药业(集团)股份有限公司
所属行业:
医药制造业
上市日期:
2011-03-22
主营业务:
福安药业(集团)股份有限公司主要从事化学药品的研发、生产、销售。主要产品有抗生素类(包括原料药、制剂不同规格)、抗肿瘤类、特色专科药类等药物。
发行价格:
41.88
{"stockData":{"symbol":"300194","market":"SZ","secType":"STK","nameCN":"福安药业","latestPrice":4.35,"timestamp":1740639792000,"preClose":4.37,"halted":0,"volume":23045200,"delay":0,"changeRate":-0.0046,"floatShares":968000000,"shares":1190000000,"eps":0.2368,"marketStatus":"已收盘","change":-0.02,"latestTime":"02-27 15:00:00","open":4.37,"high":4.4,"low":4.3,"amount":100000000,"amplitude":0.0229,"askPrice":4.35,"askSize":1247,"bidPrice":4.34,"bidSize":2890,"shortable":0,"etf":0,"ttmEps":0.2368,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1740706200000},"marketStatusCode":5,"adr":0,"adjPreClose":4.37,"symbolType":"stock","openAndCloseTimeList":[[1740619800000,1740627000000],[1740632400000,1740639600000]],"highLimit":4.81,"lowLimit":3.93,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1189712382,"isCdr":false,"pbRate":1.18,"roa":"--","peRate":18.369932,"roe":"7.06%","epsLYR":0.19,"committee":-0.058272,"marketValue":5175000000,"turnoverRate":0.0238,"status":1,"floatMarketCap":4210000000},"requestUrl":"/m/hq/s/300194","defaultTab":"news","newsList":[{"id":"2514804653","title":"福安药业:公司目前并未开展具体的AI研究项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2514804653","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514804653?lang=zh_cn&edition=full","pubTime":"2025-02-27 21:00","pubTimestamp":1740661219,"startTime":"0","endTime":"0","summary":"然而,公司目前并未开展具体的AI研究项目,也未将AI技术正式应用于管线研发或其他业务环节。公司始终关注新兴技术的发展,并会基于实际业务需求和战略规划,审慎评估包括AI在内的各项技术的应用前景。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022700039554.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0028","BK0132","300194","BK0239"],"gpt_icon":0},{"id":"2514385097","title":"福安药业:公司目前没有接入AI智能创新药领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385097","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385097?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:51","pubTimestamp":1740660660,"startTime":"0","endTime":"0","summary":"有投资者向福安药业提问, 公司是否接入AI智能创新药?公司回答表示,您好,公司目前没有接入AI智能创新药领域,谢谢!\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-02-27/doc-inemxvsi0692951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0060","300194","BK1574","BK1161","BK0239","BK0132","BK0028","159992","159819","06978"],"gpt_icon":0},{"id":"2514252886","title":"福安药业最新公告:子公司收到药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2514252886","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514252886?lang=zh_cn&edition=full","pubTime":"2025-02-26 16:56","pubTimestamp":1740560192,"startTime":"0","endTime":"0","summary":"福安药业公告称,公司全资子公司福安药业集团湖北人民制药有限公司于近日收到国家药品监督管理局签发的药品注册证书,药品名称为吲哚布芬片,注册分类为化药3类,规格为0.1g和0.2g。该药品适用于动脉硬化引起的缺血性心血管病变、缺血性脑血管病变,静脉血栓形成。截止目前,该药品已有13家企业通过一致性评价或视同通过一致性评价。上述药品注册证书的获得将进一步丰富子公司产品线,提升其市场竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022600029258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","300194","BK0239","BK0028","BK0132"],"gpt_icon":0},{"id":"2514363007","title":"福安药业(300194.SZ):吲哚布芬片获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2514363007","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514363007?lang=zh_cn&edition=full","pubTime":"2025-02-26 15:56","pubTimestamp":1740556593,"startTime":"0","endTime":"0","summary":"智通财经APP讯,福安药业(300194.SZ)公告,公司全资子公司福安药业集团湖北人民制药有限公司(简称“人民制药”)于近日收到国家药品监督管理局签发的药品注册证书,相关药品名称为:吲哚布芬片。吲哚布芬片适用于动脉硬化引起的缺血性心血管病变、缺血性脑血管病变,静脉血栓形成。也可用于血液透析时预防血栓形成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254576.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0028","300194","BK0132","BK0060"],"gpt_icon":0},{"id":"2514065360","title":"福安药业:公司的主要业务为化学制药,目前暂无中药种植基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2514065360","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514065360?lang=zh_cn&edition=full","pubTime":"2025-02-25 17:30","pubTimestamp":1740475821,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)02月25日在投资者关系平台上答复投资者关心的问题。投资者:公司有多少亩中药种植基地?中药的崛起靠自己了!福安药业董秘:公司的主要业务为化学制药,目前暂无中药种植基地,谢谢!以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022500030827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0028","01477","BK0060","BK1574","BK0132","BK0239","BK1191"],"gpt_icon":0},{"id":"2514063048","title":"福安药业2月25日现1笔大宗交易 成交金额915.99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514063048","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514063048?lang=zh_cn&edition=full","pubTime":"2025-02-25 17:00","pubTimestamp":1740474000,"startTime":"0","endTime":"0","summary":" 2月25日,福安药业收跌1.14%,收盘价为4.34元,发生1笔大宗交易,合计成交量215.02万股,成交金额915.99万元。 进一步统计,近3个月内该股累计发生1笔大宗交易,合计成交金额为915.99万元。该股近5个交易日累计上涨0.23%,主力资金合计净流出2645.82万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-02-25/doc-inemswvz4415130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0132","BK0239","300194","BK0028","BK0060"],"gpt_icon":0},{"id":"2512920915","title":"福安药业:公司目前没有海外大麻业务,除产品出口外无其他相关海外业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2512920915","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512920915?lang=zh_cn&edition=full","pubTime":"2025-02-17 15:30","pubTimestamp":1739777413,"startTime":"0","endTime":"0","summary":"福安药业董秘:您好,感谢您的关注,公司2025年将继续做好生产经营各项工作,在现有基础上能够稳定发展,谢谢!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021700014008.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0132","BK0060","BK0028","BK0239"],"gpt_icon":0},{"id":"2511645532","title":"每周股票复盘:福安药业(300194)子公司获药品注册证书,丰富产品线提升竞争力","url":"https://stock-news.laohu8.com/highlight/detail?id=2511645532","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511645532?lang=zh_cn&edition=full","pubTime":"2025-02-15 06:41","pubTimestamp":1739572868,"startTime":"0","endTime":"0","summary":"截至2025年2月14日收盘,福安药业报收于4.49元,较上周的4.48元上涨0.22%。本周关注点公司公告汇总:福安药业全资子公司获得盐酸咪达唑仑口服溶液药品注册证书公司公告汇总福安药业(集团)股份有限公司全资子公司福安药业集团湖北人民制药有限公司近日收到国家药品监督管理局签发的药品注册证书。药品注册证书的获得将进一步丰富子公司产品线,提升其市场竞争力。福安药业(集团)股份有限公司董事会二〇二五年二月十日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021500009910.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0028","BK0060","BK0132","BK0239"],"gpt_icon":0},{"id":"2510238278","title":"福安药业:公司将进一步严格遵守环保法规,达标合规排放","url":"https://stock-news.laohu8.com/highlight/detail?id=2510238278","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510238278?lang=zh_cn&edition=full","pubTime":"2025-02-11 12:00","pubTimestamp":1739246416,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)02月10日在投资者关系平台上答复投资者关心的问题。投资者:您好,我是一名市民,一直很关注空气质量问题。想请问贵公司有没有为防范空气污染采取一些措施?我们居民都希望生活在一个空气清新的城市里,期待贵公司能在其中发挥积极作用福安药业董秘:您好,感谢您的关注,公司将进一步严格遵守环保法规,达标合规排放,在做好生产经营的同时,在城市环境保护和建设中发挥积极作用,谢谢!以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021100016137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","300194","BK0028","BK0132"],"gpt_icon":0},{"id":"2510583573","title":"福安药业最新公告:子公司收到盐酸咪达唑仑口服溶液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2510583573","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510583573?lang=zh_cn&edition=full","pubTime":"2025-02-10 16:56","pubTimestamp":1739177766,"startTime":"0","endTime":"0","summary":"福安药业公告称,公司全资子公司福安药业集团湖北人民制药有限公司近日收到国家药品监督管理局签发的药品注册证书,药品名称为盐酸咪达唑仑口服溶液,适用于儿童诊断或治疗性操作前以及操作过程中的镇静、抗焦虑、遗忘;也可用于儿童术前镇静、抗焦虑、遗忘。该药品已有2家企业(含人民制药)通过一致性评价或视同通过一致性评价。药品注册证书的获得将进一步丰富子公司产品线,提升其市场竞争力。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021000021065.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","300194","BK0060","BK0239","BK0028"],"gpt_icon":0},{"id":"2510352880","title":"福安药业(300194.SZ)全资子公司收到药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2510352880","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510352880?lang=zh_cn&edition=full","pubTime":"2025-02-10 16:01","pubTimestamp":1739174519,"startTime":"0","endTime":"0","summary":"通财经APP讯,福安药业(300194.SZ)公告,公司全资子公司福安药业集团湖北人民制药有限公司(简称“人民制药”)于近日收到国家药品监督管理局签发的药品注册证书,药品名称为盐酸咪达唑仑口服溶液,用于儿童诊断或治疗性操作前以及操作过程中的镇静、抗焦虑、遗忘;也可用于儿童术前镇静、抗焦虑、遗忘。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1247724.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0060","BK0239","BK0132","300194"],"gpt_icon":0},{"id":"2509441922","title":"福安药业:截止1月27日,公司股东户数为41762户","url":"https://stock-news.laohu8.com/highlight/detail?id=2509441922","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509441922?lang=zh_cn&edition=full","pubTime":"2025-02-06 17:00","pubTimestamp":1738832415,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)02月06日在投资者关系平台上答复投资者关心的问题。投资者:请问截止1月27日股东收盘公司人数是多少?谢谢!福安药业董秘:截止1月27日,公司股东户数为41762户,谢谢!以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025020600026591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0132","BK0028","BK0239","BK0060"],"gpt_icon":0},{"id":"2503469335","title":"福安药业:截止1月10日,公司股东户数为41792户","url":"https://stock-news.laohu8.com/highlight/detail?id=2503469335","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503469335?lang=zh_cn&edition=full","pubTime":"2025-01-14 17:00","pubTimestamp":1736845215,"startTime":"0","endTime":"0","summary":"证券之星消息,福安药业(300194)01月14日在投资者关系平台上答复投资者关心的问题。投资者:尊敬的董秘您好!请问1月10日公司股东人数多少?谢谢!福安药业董秘:截止1月10日,公司股东户数为41792户,谢谢!以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011400028827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0060","BK0132","BK0028","BK0239"],"gpt_icon":0},{"id":"2502014315","title":"福安药业:子公司二甲双胍恩格列净片获药品注册证书 有助于进一步丰富其产品线","url":"https://stock-news.laohu8.com/highlight/detail?id=2502014315","media":"中国财富通","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502014315?lang=zh_cn&edition=full","pubTime":"2025-01-09 21:13","pubTimestamp":1736428397,"startTime":"0","endTime":"0","summary":"中国财富通1月9日 - 福安药业(300194)公告称,公司全资子公司福安药业集团庆余堂制药有限公司于近日收到国家药品监督管理局签发的药品注册证书,药品名称为二甲双胍恩格列净片。上述药品注册证书的获得将进一步丰富子公司产品线,提升其市场竞争力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=V7wt8dESLEo%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0132","BK0060","BK0028","300194","BK0239"],"gpt_icon":0},{"id":"2502980830","title":"福安药业最新公告:子公司庆余堂收到药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2502980830","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502980830?lang=zh_cn&edition=full","pubTime":"2025-01-09 16:53","pubTimestamp":1736412784,"startTime":"0","endTime":"0","summary":"福安药业公告,公司全资子公司庆余堂近日收到国家药品监督管理局签发的药品注册证书,药品名称为二甲双胍恩格列净片,适应症为配合饮食控制和运动,适用于正在接受恩格列净和盐酸二甲双胍治疗的2型糖尿病成人患者,用于改善这些患者的血糖控制。该药品已有17家企业(含庆余堂)通过一致性评价或视同通过一致性评价。药品注册证书的获得将丰富子公司产品线,提升市场竞争力,但产品的生产、销售情况及对公司业绩的具体影响存在不确定性。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010900026553.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","300194","BK0028","BK0060"],"gpt_icon":0},{"id":"2502062782","title":"福安药业(300194.SZ):二甲双胍恩格列净片取得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2502062782","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502062782?lang=zh_cn&edition=full","pubTime":"2025-01-09 16:10","pubTimestamp":1736410246,"startTime":"0","endTime":"0","summary":"智通财经APP讯,福安药业(300194.SZ)公告,公司全资子公司福安药业集团庆余堂制药有限公司(简称“庆余堂”)于近日收到国家药品监督管理局签发的药品注册证书,相关药品名称为:二甲双胍恩格列净片。公告显示,二甲双胍恩格列净片适应症为:本品配合饮食控制和运动,适用于正在接受恩格列净和盐酸二甲双胍治疗的2型糖尿病成人患者,用于改善这些患者的血糖控制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1235446.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0060","BK0239","BK0132","300194"],"gpt_icon":0},{"id":"2501766391","title":"福安药业(300194)1月7日主力资金净买入1577.29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501766391","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501766391?lang=zh_cn&edition=full","pubTime":"2025-01-08 09:21","pubTimestamp":1736299274,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2025年1月7日收盘,福安药业报收于4.45元,下跌1.98%,换手率3.92%,成交量37.96万手,成交额1.67亿元。近5日资金流向一览见下表:福安药业融资融券信息显示,融资方面,当日融资买入2223.61万元,融资偿还1418.13万元,融资净买入805.48万元。福安药业主营业务:从事化学药品的研发、生产、销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010800008147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","300194","BK0132","BK0060"],"gpt_icon":0},{"id":"2501402971","title":"1月6日福安药业涨5.83%,万家国证2000指数增强A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2501402971","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501402971?lang=zh_cn&edition=full","pubTime":"2025-01-06 16:15","pubTimestamp":1736151309,"startTime":"0","endTime":"0","summary":"证券之星消息,1月6日福安药业涨5.83%,收盘报4.54元,换手率5.49%,成交量53.18万手,成交额2.38亿元。重仓福安药业的公募基金请见下表:根据2024基金Q3季报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为万家国证2000指数增强A。万家国证2000指数增强A目前规模为3.77亿元,最新净值0.9445,较上一交易日下跌3.19%,近一年下跌3.6%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010600021706.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0132","BK0239","300194","399303","BK0028","159628"],"gpt_icon":0},{"id":"2495686682","title":"福安药业:公司股东户数为42156户","url":"https://stock-news.laohu8.com/highlight/detail?id=2495686682","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495686682?lang=zh_cn&edition=full","pubTime":"2024-12-31 08:39","pubTimestamp":1735605591,"startTime":"0","endTime":"0","summary":"金融界12月31日消息,有投资者在互动平台向福安药业提问:请问截止12月20日最新的股东人数是多少?谢谢。公司回答表示:截止12月20日,公司股东户数为42156户。\n\n\r\n 责任编辑:栎树","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2024/12/31083946966900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300194","BK0132","BK0060","BK0028","BK0239"],"gpt_icon":0},{"id":"2495686526","title":"福安药业:子公司持有富马酸替诺福韦二吡呋酯原料药批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2495686526","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495686526?lang=zh_cn&edition=full","pubTime":"2024-12-31 08:39","pubTimestamp":1735605589,"startTime":"0","endTime":"0","summary":"金融界12月31日消息,有投资者在互动平台向福安药业提问:请问贵司有针对HIV病毒和艾滋病的预防和治疗药物吗?治疗效果如何,谢谢!公司回答表示:公司目前没有生产销售针对艾滋病治疗的制剂药品,子公司持有富马酸替诺福韦二吡呋酯原料药批件。\n\n\r\n 责任编辑:栎树","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2024/12/31083946966902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK0060","BK0132","300194","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1740701973207,"stockEarnings":[{"period":"1week","weight":-0.0114},{"period":"1month","weight":0.0023},{"period":"3month","weight":-0.1437},{"period":"6month","weight":0.0875},{"period":"1year","weight":0.2376},{"period":"ytd","weight":-0.0247}],"compareEarnings":[{"period":"1week","weight":0.0111},{"period":"1month","weight":0.0423},{"period":"3month","weight":0.0185},{"period":"6month","weight":0.192},{"period":"1year","weight":0.1454},{"period":"ytd","weight":0.0108}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"福安药业(集团)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"41762人(较上一季度减少0.67%)","perCapita":"23175股","listingDate":"2011-03-22","address":"重庆市长寿区化南一路1号","registeredCapital":"118971万元","survey":" 福安药业(集团)股份有限公司主要从事化学药品的研发、生产、销售。主要产品有抗生素类(包括原料药、制剂不同规格)、抗肿瘤类、特色专科药类等药物。","listedPrice":41.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.2","shortVersion":"4.31.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福安药业(300194)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福安药业,300194,福安药业股票,福安药业股票老虎,福安药业股票老虎国际,福安药业行情,福安药业股票行情,福安药业股价,福安药业股市,福安药业股票价格,福安药业股票交易,福安药业股票购买,福安药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福安药业(300194)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}